Medical Weight Loss for Greenville, North Carolina Residents

Greenville, North Carolina residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Greenville through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Greenville residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your North Carolina telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Greenville Residents Choose New Hope Weight Loss

New Hope keeps the money part simple so you can focus on the health part. For Greenville patients that means semaglutide from $166 monthly, tirzepatide from $233 monthly, a $119 physician visit, no insurance required, and no penalty for living outside Costa Mesa. We take HSA, FSA, Klarna, and Affirm, so paying out of pocket does not have to mean paying all at once. Clear terms, no games.

Greenville residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Greenville address.

People throughout Greenville reach the same physician-supervised care that built our reputation in Costa Mesa, and they do it from home, because telehealth erases the gap between North Carolina and California. We care for patients throughout downtown Greenville, the university area, and the greater Pitt County area of eastern North Carolina. Semaglutide starts from $166 a month, or $499 for the 90-day program, and tirzepatide from $233 a month, the same pricing for every North Carolina patient.

Patients on the outskirts of North Carolina get the same flat pricing, the same physician, and the same fast start as those near the center of Greenville. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Greenville patients. Across fast-growing North Carolina, New Hope Weight Loss provides physician-supervised GLP-1 care by telehealth from our Costa Mesa, California clinic, with no need to travel for a visit.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Greenville patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Greenville

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Greenville home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Greenville

Where is the closest New Hope Weight Loss to Greenville?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Greenville, North Carolina patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Greenville?

It is not. We run a complete telehealth model, so people in Greenville handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Greenville using cold-pack insulation that keeps it stable until it reaches you.

What should a Greenville patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Greenville patients are not charged any extra distance fee.

What areas of Greenville do you serve?

We serve patients from across Greenville by telehealth, including downtown Greenville, the university area, and the greater Pitt County area of eastern North Carolina.

Are there hidden fees for Greenville patients?

No. Greenville patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Greenville Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Greenville, North Carolina by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.